Mass. biotech companies still raising venture capital

07/7/2008 | Boston Globe (tiered subscription model), The

Biotech companies in Massachusetts continue to gain investments amid a declining stock market and dwindling initial public offerings. Agios Pharmaceuticals, a Boston-based firm working on drugs designed to starve cancerous cells, has secured $33 million in venture capital. Concert Pharmaceuticals and Constellation Pharmaceuticals also each have raised more than $30 million this year.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA